USPTO serial 85782374
SCITERION
Reviewed by CopyMark Law Group
Reg. 4786218Status 710
- Filing date
- Status date
- Registration date
- Aug 4, 2015
- Examiner
- MCCAULEY, BRENDAN D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SCITERION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Hae Park-Suk
Hae Park-Suk Nixon & Vanderhye, P.C.901 N. Glebe Road11th FloorArlington, VA 22203Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Medical affairs optimization, namely, business management and organization consultancy for the optimization of strategies and tactics to enable effective communication to stakeholders at all stages of development, clinical through commercial; Business consultation services, namely, identifying and ranking of opinion and thought leaders in the fields of scientific, medical, pharmaceuticals and healthcare; Scientific story creation and development, namely, custom writing comprising public relations and marketing materials for the scientific, pharmaceutical, medical and healthcare industries; Publications planning, namely, assistance, advisory services and consultancy with regard to strategic publication and publication channels of marketing and promotional materials in the fields of pharmaceuticals, healthcare, clinical data, clinical research, and advocacy; Advertising agency services in the medical, pharmaceutical and health fields; Advertising and marketing consultation in the healthcare field; Business marketing research in the healthcare field; Cooperative advertising and marketing services for the pharmaceutical industry; Creating advertising materials in the nature of posters for conventions, symposia and seminars, in the fields of science, health, pharmaceuticals, and medicine; Business services, namely, procuring qualified and credentialed third-party experts, professionals and other qualified personnel, and documentation on behalf of others; Providing market intelligence and business communications strategy development services to the scientific, pharmaceutical, medical and healthcare industries; Providing market intelligence and business communications strategy development services to the scientific, pharmaceutical, medical and healthcare industries in the areas of in the areas of advisory board development, publication planning, speaker training, and physician education; Medical writing services for advertising purposes, namely, custom writing of scientific key opinion leaders strategy, print and online publications and strategy, scientific and medical slide presentations | SECTION 8 - CANCELLED | — |
| 041 | Educational services, namely, organizing panels of medical experts to speak at medical educational programs and development of the educational materials in the nature of the content and presentations of others in the fields of science, medicine, and health; Development and dissemination of reports of others of proceedings of medical education programs and meetings of national and international advisory boards in the field of science, medicine, pharmaceutical and health; Educational services, namely, conducting medical and marketing strategic alignment workshops; Organization, planning and development of conventions, symposia, and seminars, in the fields of science, health, pharmaceuticals, and medicine; Custom writing services for non-advertising purposes in the nature of reports for conventions, symposia, and seminars in the fields of science, health, pharmaceuticals and medicine; Educational services in the nature of development, creation, production and post-production services of multimedia educational videos featuring animation, medical animation, thought leader video snippets, information graphics and medical education, provided via interactive and non-interactive websites, webpages, podcasts and webcasts, interactive and non-interactive audio, audio-visual applications for mobile platforms; Development of interactive videos, namely, video editing, video mastering, video production, recording of video, audio, animation, medical animation, thought leader video snippets, information graphics, and medical education; Educational services, namely, developing and disseminating printed educational materials via online and kiosk-based interactive programs in the fields of science, medicine, healthcare and pharmaceuticals; Provision of medical education services to health care professionals and healthcare sales representatives, namely, arranging and conducting national symposia, teleconferences, conferences, roundtables, meetings, seminars, webcasts, conventions, visiting faculty programs, and distributing course materials in connection therewith; Providing training of speakers to participate in medical education programs; Medical education services, namely, conducting training classes in the field of prescription drug advertising and marketing in the field of medical education to effectively communicate their scientific communication plans and strategies; Arranging and conducting educational colloquiums, conferences, seminars and symposiums in the field of healthcare; Custom medical writing services for non-advertising purposes, namely, custom writing of narratives and summaries of research, safety narratives, and other regulatory reports, and news reporting of scientific conferences and continuing health and other education events; Medical writing services for non-advertising purposes, namely, custom writing of medical educational, medical training texts; Custom writing for non-advertising purposes of scientific platform, science visualization, and medical analysis; Medical writing services for non-advertising purposes, namely, custom writing of scientific key opinion leaders strategy, print and online publications and strategy, scientific and medical slide presentations; Organizing and conducting medical conventions and congresses, including organizing, presentation and conducting of science, healthcare, pharmaceutical, and medical conventions and congresses, including identifying speakers and advocates, advising as to convention and congress strategy, advisory board strategy, meeting reporters strategy; Custom writing for non-advertising purposes of medical supplements, journal articles, slide presentations, narrative reviews, and medical information letters; Medical writing for non-advertising purposes of medical papers and medical publications | SECTION 8 - CANCELLED | — |
| 042 | Technical medical writing for others; Technical medical writing of medical papers and medical publications; Development of interactive videos, namely, design for others in the field of interactive videos featuring video, audio, animation, medical animation, mechanisms of action, thought leader video snippets, information graphics, and medical education; Design of interactive videos, namely, computer-aided design of video graphics | SECTION 8 - CANCELLED | — |
| 044 | Providing medical information services to physicians concerning health and medical related issues | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Havas, S.A.
- Other trademarks owned by Havas, S.A.
- Other trademarks owned by Havas, S.A.
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SCITERION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 11, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 4, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 26, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 4, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 1, 2015 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 30, 2015 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 30, 2015 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 30, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 2, 2015 | IUAF | USE AMENDMENT FILED | — |
| Jun 2, 2015 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 4, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 2, 2014 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 2, 2014 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 2, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 3, 2014 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 8, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 8, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 19, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 4, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 4, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 4, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 17, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 17, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 17, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 30, 2013 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 30, 2013 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 30, 2013 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 26, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 26, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2013 | ALIE | ASSIGNED TO LIE | — |
| Sep 16, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 27, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 22, 2012 | NWAP | NEW APPLICATION ENTERED | — |